Nasal Polyps Treatment Market Report

Global and Region Nasal Polyps Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：214
  • REPORT CODE：GMM913907
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Nasal Polyps Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nasal Polyps Treatmentmarket, defines the market attractiveness level of Nasal Polyps Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nasal Polyps Treatment industry, describes the types of Nasal Polyps Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nasal Polyps Treatment market and the development prospects and opportunities of Nasal Polyps Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nasal Polyps Treatment market in Chapter 13.

    By Player:

    • F Hoffmann-La Roche AG

    • Novartis International AG

    • Intersect ENT Inc

    • Norton Waterford Ltd

    • Regeneron Pharmaceuticals Inc

    • Merck & Co Inc

    • OptiNose US

    • Pfizer Inc

    • Teva Pharmaceutical Industries Ltd

    • Sanofi SA

    • GlaxoSmithKline PLC

    By Type:

    • Pharmacological Therapies

    • Surgeries

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Specialty Clinics

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nasal Polyps Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nasal Polyps Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nasal Polyps Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nasal Polyps Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nasal Polyps Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Nasal Polyps Treatment Consumption (2017-2022)

    • 7.2 United States Nasal Polyps Treatment Consumption (2017-2022)

    • 7.3 Europe Nasal Polyps Treatment Consumption (2017-2022)

    • 7.4 China Nasal Polyps Treatment Consumption (2017-2022)

    • 7.5 Japan Nasal Polyps Treatment Consumption (2017-2022)

    • 7.6 India Nasal Polyps Treatment Consumption (2017-2022)

    • 7.7 South Korea Nasal Polyps Treatment Consumption (2017-2022)

    8 Region and Country-wise Nasal Polyps Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Nasal Polyps Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Nasal Polyps Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Nasal Polyps Treatment Consumption Forecast (2022-2028)

    • 8.4 China Nasal Polyps Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Nasal Polyps Treatment Consumption Forecast (2022-2028)

    • 8.6 India Nasal Polyps Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Nasal Polyps Treatment Consumption Forecast (2022-2028)

    9 Global Nasal Polyps Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Nasal Polyps Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Pharmacological Therapies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Surgeries Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nasal Polyps Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    10 Global Nasal Polyps Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Nasal Polyps Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Pharmacological Therapies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Surgeries Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nasal Polyps Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nasal Polyps Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nasal Polyps Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nasal Polyps Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nasal Polyps Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nasal Polyps Treatment Market Competitive Analysis

    • 14.1 F Hoffmann-La Roche AG

      • 14.1.1 F Hoffmann-La Roche AG Company Details

      • 14.1.2 F Hoffmann-La Roche AG Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 F Hoffmann-La Roche AG Nasal Polyps Treatment Product and Service

    • 14.2 Novartis International AG

      • 14.2.1 Novartis International AG Company Details

      • 14.2.2 Novartis International AG Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis International AG Nasal Polyps Treatment Product and Service

    • 14.3 Intersect ENT Inc

      • 14.3.1 Intersect ENT Inc Company Details

      • 14.3.2 Intersect ENT Inc Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Intersect ENT Inc Nasal Polyps Treatment Product and Service

    • 14.4 Norton Waterford Ltd

      • 14.4.1 Norton Waterford Ltd Company Details

      • 14.4.2 Norton Waterford Ltd Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Norton Waterford Ltd Nasal Polyps Treatment Product and Service

    • 14.5 Regeneron Pharmaceuticals Inc

      • 14.5.1 Regeneron Pharmaceuticals Inc Company Details

      • 14.5.2 Regeneron Pharmaceuticals Inc Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Regeneron Pharmaceuticals Inc Nasal Polyps Treatment Product and Service

    • 14.6 Merck & Co Inc

      • 14.6.1 Merck & Co Inc Company Details

      • 14.6.2 Merck & Co Inc Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck & Co Inc Nasal Polyps Treatment Product and Service

    • 14.7 OptiNose US

      • 14.7.1 OptiNose US Company Details

      • 14.7.2 OptiNose US Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 OptiNose US Nasal Polyps Treatment Product and Service

    • 14.8 Pfizer Inc

      • 14.8.1 Pfizer Inc Company Details

      • 14.8.2 Pfizer Inc Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Inc Nasal Polyps Treatment Product and Service

    • 14.9 Teva Pharmaceutical Industries Ltd

      • 14.9.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.9.2 Teva Pharmaceutical Industries Ltd Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Teva Pharmaceutical Industries Ltd Nasal Polyps Treatment Product and Service

    • 14.10 Sanofi SA

      • 14.10.1 Sanofi SA Company Details

      • 14.10.2 Sanofi SA Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sanofi SA Nasal Polyps Treatment Product and Service

    • 14.11 GlaxoSmithKline PLC

      • 14.11.1 GlaxoSmithKline PLC Company Details

      • 14.11.2 GlaxoSmithKline PLC Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 GlaxoSmithKline PLC Nasal Polyps Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nasal Polyps Treatment

    • Figure Nasal Polyps Treatment Picture

    • Table Global Nasal Polyps Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nasal Polyps Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nasal Polyps Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nasal Polyps Treatment Consumption by Country (2017-2022)

    • Figure United States Nasal Polyps Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Nasal Polyps Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Nasal Polyps Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Nasal Polyps Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Nasal Polyps Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nasal Polyps Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Nasal Polyps Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Nasal Polyps Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nasal Polyps Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nasal Polyps Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nasal Polyps Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nasal Polyps Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nasal Polyps Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacological Therapies Consumption and Growth Rate (2017-2022)

    • Figure Global Surgeries Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacological Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgeries Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nasal Polyps Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nasal Polyps Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table F Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche AG Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche AG Nasal Polyps Treatment Product and Service

    • Table Novartis International AG (Foundation Year, Company Profile and etc.)

    • Table Novartis International AG Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International AG Nasal Polyps Treatment Product and Service

    • Table Intersect ENT Inc (Foundation Year, Company Profile and etc.)

    • Table Intersect ENT Inc Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intersect ENT Inc Nasal Polyps Treatment Product and Service

    • Table Norton Waterford Ltd (Foundation Year, Company Profile and etc.)

    • Table Norton Waterford Ltd Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Norton Waterford Ltd Nasal Polyps Treatment Product and Service

    • Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Inc Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Nasal Polyps Treatment Product and Service

    • Table Merck & Co Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Inc Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Nasal Polyps Treatment Product and Service

    • Table OptiNose US (Foundation Year, Company Profile and etc.)

    • Table OptiNose US Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table OptiNose US Nasal Polyps Treatment Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Nasal Polyps Treatment Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Nasal Polyps Treatment Product and Service

    • Table Sanofi SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi SA Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Nasal Polyps Treatment Product and Service

    • Table GlaxoSmithKline PLC (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline PLC Nasal Polyps Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline PLC Nasal Polyps Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US